Allianz (ALIZF,$208.00) posts Q1 results; revenue is up +6.2% year-over-year
Allianz reported first quarter operating profit of 3.2 billion euros – which remains solid, albeit with a mild, -2.9% decrease amidst higher claims from natural catastrophes.
The insurance company’s total revenues in the quarter were 44.0 billion euros, up +6.2% from the year-ago quarter. Internal revenue growth (which adjusts for foreign currency translation and consolidation effects) was +3.8%, on the back of growth in all business segments.
According to the company, Property-Casualty business experienced strong internal growth, driven by “healthy pricing and robust volume growth”. Operating profit was impacted by the highest level of claims from natural catastrophes for a first-quarter in a decade, the company stated.
In Life/Health, solid improvement in new business margin and value was due to improved business mix and increase in volumes across most entities – thereby auguring well for the company's future profitability, according to the company.
Allianz mentioned that its Asset Management business had a “very strong” first-quarter in operating profit.
Looking ahead, Allianz confirmed its 2022 operating profit outlook at 13.4 billion euros (plus or minus 1 billion euros).
ALIZF in upward trend: price rose above 50-day moving average on November 24, 2025
ALIZF moved above its 50-day moving average on November 24, 2025 date and that indicates a change from a downward trend to an upward trend. In of 71 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .
Technical Analysis (Indicators)
Bullish Trend Analysis
The Moving Average Convergence Divergence (MACD) for ALIZF just turned positive on November 11, 2025. Looking at past instances where ALIZF's MACD turned positive, the stock continued to rise in of 56 cases over the following month. The odds of a continued upward trend are .
The 10-day moving average for ALIZF crossed bullishly above the 50-day moving average on November 19, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 21 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ALIZF advanced for three days, in of 237 cases, the price rose further within the following month. The odds of a continued upward trend are .
Bearish Trend Analysis
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
The Momentum Indicator moved below the 0 level on November 28, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on ALIZF as a result. In of 132 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ALIZF declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for ALIZF entered a downward trend on November 17, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 39, placing this stock better than average.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.319) is normal, around the industry mean (1.963). P/E Ratio (13.548) is within average values for comparable stocks, (14.045). Projected Growth (PEG Ratio) (1.428) is also within normal values, averaging (1.361). Dividend Yield (0.040) settles around the average of (0.045) among similar stocks. P/S Ratio (1.057) is also within normal values, averaging (1.480).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ALIZF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
Industry MultiLineInsurance
Advertisement